{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:40:41Z","timestamp":1760838041116,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"am","delay-in-days":701,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H04057","19K17746","22K19755"],"award-info":[{"award-number":["19H04057","19K17746","22K19755"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012701","name":"Saga University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["2453"],"award-info":[{"award-number":["2453"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bmc.2022.117039","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T04:03:10Z","timestamp":1664424190000},"page":"117039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Improving lipophilicity of 5-(1-acetyl-5-phenylpyrazolidin-3-ylidene)-1,3-dimethylbarbituric acid increases its efficacy to activate hypoxia-inducible factors"],"prefix":"10.1016","volume":"73","author":[{"given":"Kento","family":"Sonoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Ujike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akito","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6100-3350","authenticated-orcid":false,"given":"Norio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4140-9959","authenticated-orcid":false,"given":"Shin-ichi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadayuki","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.117039_b0005","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmc.2022.117039_b0010","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","article-title":"General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2022.117039_b0015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2022.117039_b0020","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","article-title":"Hypoxia-inducible factors and the response to hypoxic stress","volume":"40","author":"Majmundar","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2022.117039_b0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-induced angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2022.117039_b0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","article-title":"Role of HIF-1\u03b1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis","volume":"394","author":"Carmeliet","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2022.117039_b0035","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/01.ASN.0000074239.22357.06","article-title":"Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats","volume":"14","author":"Matsumoto","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bmc.2022.117039_b0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jcp.20166","article-title":"Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer","volume":"202","author":"Macheda","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bmc.2022.117039_b0045","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmc.2022.117039_b0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2022.117039_b0055","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1021\/jm400386j","article-title":"Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: Tricking the body into mounting orchestrated survival and repair responses","volume":"56","author":"Rabinowitz","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.117039_b0060","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1038\/ncomms13312","article-title":"Potent and selective chemical probe of hypoxic signalling downstream of HIF-\u03b1 hydroxylation via VHL inhibition","volume":"7","author":"Frost","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2022.117039_b0065","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrneph.2015.82","article-title":"Anaemia in kidney disease: Harnessing hypoxia responses for therapy","volume":"11","author":"Koury","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.bmc.2022.117039_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mam.2016.01.001","article-title":"Pharmacological targeting of the HIF hydroxylases - A new field in medicine development","volume":"47\u201348","author":"Chan","year":"2016","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.bmc.2022.117039_b0075","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1073\/pnas.0601283103","article-title":"Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)","volume":"103","author":"McDonough","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2022.117039_b0080","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/cdd.2008.10","article-title":"Role and regulation of prolyl hydroxylase domain proteins","volume":"15","author":"Fong","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bmc.2022.117039_b0085","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.str.2009.06.002","article-title":"Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases","volume":"17","author":"Chowdhury","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.bmc.2022.117039_b0090","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bmc.2022.117039_b0095","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bmc.2022.117039_b0100","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/MCB.25.15.6415-6426.2005","article-title":"Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1\u03b1","volume":"25","author":"Chan","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmc.2022.117039_b0105","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1039\/C7SC02103H","article-title":"Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials","volume":"8","author":"Yeh","year":"2017","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2022.117039_b0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrd2761","article-title":"Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease","volume":"8","author":"Fraisl","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2022.117039_b0115","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bmc.2022.117039_b0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000455166","article-title":"Targeting Hypoxia-inducible factors for the treatment of anemia in chronic kidney disease patients","volume":"45","author":"Locatelli","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.bmc.2022.117039_b0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1172\/JCI113564","article-title":"Erythropoietin messenger RNA levels in developing mice and transfer of 125I-erythropoietin by the placenta","volume":"82","author":"Koury","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2022.117039_b0130","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1182\/blood-2007-10-115857","article-title":"Repression via the GATA box is essential for tissue-specific erythropoietin gene expression","volume":"111","author":"Obara","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bmc.2022.117039_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00424-015-1740-2","article-title":"Roles of renal erythropoietin-producing (REP) cells in the maintenance of systemic oxygen homeostasis","volume":"468","author":"Suzuki","year":"2016","journal-title":"Pflugers Arch Eur J Physiol."},{"key":"10.1016\/j.bmc.2022.117039_b0140","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/ki.2013.74","article-title":"Van Ypersele De Strihou C. Diabetic nephropathy: Are there new and potentially promising therapies targeting oxygen biology?","volume":"84","author":"Miyata","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.bmc.2022.117039_b0145","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/acsmedchemlett.7b00404","article-title":"Discovery of JTZ-951: A HIF prolyl hydroxylase inhibitor for the treatment of renal anemia","volume":"8","author":"Ogoshi","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2022.117039_b0150","unstructured":"Duffy KJ, Fitch DM, Jin J, et al. Prolyl hydroxylase inhibitors. 2007; WO2007\/150011."},{"key":"10.1016\/j.bmc.2022.117039_b0155","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/dta.1870","article-title":"Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls","volume":"8","author":"Thevis","year":"2016","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.bmc.2022.117039_b0160","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/cmdc.201700783","article-title":"Discovery of molidustat (BAY 85\u20133934): A small-molecule oral HIF-prolyl hydroxylase (HIF-PH) inhibitor for the treatment of renal anemia","volume":"13","author":"Beck","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2022.117039_b0165","unstructured":"Desai RC, Pandya V, Patel PR. Novel quinolone derivatives. 2014; WO2014\/102818."},{"key":"10.1016\/j.bmc.2022.117039_b0170","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-019-01077-1","article-title":"Roxadustat: First global approval","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2022.117039_b0175","unstructured":"Arend MP, Flippin LA, Guenzler-pukall V, et al. Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin. 2004; WO2004\/108681."},{"key":"10.1016\/j.bmc.2022.117039_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114939","article-title":"Esterification promotes the intracellular accumulation of roxadustat, an activator of hypoxia-inducible factors, to extend its effective duration.","volume":"197","author":"Nakai","year":"2022","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.bmc.2022.117039_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114115","article-title":"Novel PHD2\/HDACs Hybrid Inhibitors Protect against Cisplatin-Induced Acute Kidney Injury","volume":"230","author":"Wei","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.117039_b0190","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/antiox11020220","article-title":"Structure-Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors","volume":"11","author":"Poloznikov","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bmc.2022.117039_b0195","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00044-020-02681-7","article-title":"Evaluation of 3-Carbamoylpropanoic Acid Analogs as Inhibitors of Human Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase Domain Enzymes","volume":"30","author":"Chong","year":"2021","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2022.117039_b0200","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1039\/c0cs00203h","article-title":"Inhibition of 2-oxoglutarate dependent oxygenases","volume":"40","author":"Rose","year":"2011","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.bmc.2022.117039_b0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tibs.2010.07.002","article-title":"Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases","volume":"36","author":"Loenarz","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bmc.2022.117039_b0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1021\/acsptsci.2c00002","article-title":"Prolyl hydroxylase domain protein inhibitor not harboring a 2-oxoglutarate scaffold protects against hypoxic stress","volume":"5","author":"Sonoda","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.bmc.2022.117039_b0215","unstructured":"Kawaguchi S-i, Tsujita T. Novel nitrogen-containing cyclic compounds and their applications. 2022; WO\/2022\/080346."},{"key":"10.1016\/j.bmc.2022.117039_b0220","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1080\/00397911.2013.853801","article-title":"Highly efficient synthesis of trioxopyrimidine-based chalconoids under solvent-free conditions","volume":"44","author":"Gorovoy","year":"2014","journal-title":"Synth Commun"},{"key":"10.1016\/j.bmc.2022.117039_b0225","doi-asserted-by":"crossref","unstructured":"Kaylor JJ, Risley JM. Synthesis of N4-(2-Acetamido-2-Deoxy-\u03b2-d-Glucopyranosyl)-l-Asparagine analogues. n-Butyramide, 3-Chloropropionamide, 3-Aminopropionamide, and Isovaleramide analogues. Carbohydr. Res. 2001;331(4):439-444. doi:10.1016\/S0008-6215(01)00057-X.","DOI":"10.1016\/S0008-6215(01)00057-X"},{"key":"10.1016\/j.bmc.2022.117039_b0230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1620\/tjem.235.151","article-title":"Hypoxia-sensitive reporter system for high-throughput screening","volume":"235","author":"Tsujita","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.bmc.2022.117039_b0235","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2022.117039_b0240","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ymthe.2018.05.004","article-title":"Differential but complementary HIF1\u03b1 and HIF2\u03b1 transcriptional regulation","volume":"26","author":"Downes","year":"2018","journal-title":"Mol Ther."},{"key":"10.1016\/j.bmc.2022.117039_b0245","doi-asserted-by":"crossref","first-page":"e46401","DOI":"10.15252\/embr.201846401","article-title":"Inherent DNA\u2010binding specificities of the HIF\u20101\u03b1 and HIF\u20102\u03b1 transcription factors in chromatin","volume":"20","author":"Smythies","year":"2019","journal-title":"EMBO Rep"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622004321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622004321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:21:20Z","timestamp":1760836880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622004321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":49,"alternative-id":["S0968089622004321"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117039","relation":{},"ISSN":["0968-0896"],"issn-type":[{"type":"print","value":"0968-0896"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving lipophilicity of 5-(1-acetyl-5-phenylpyrazolidin-3-ylidene)-1,3-dimethylbarbituric acid increases its efficacy to activate hypoxia-inducible factors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.117039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117039"}}